The increase in TCR convergence scores provides an additional indication of the emergence of MC38-EpCAM tumor immunogenicity and of the T-cell responses to tumor neoantigens induced by C215Fab-SEA but not by anti-PD1. The gene discussed is EPCAM; the disease is neoplasm.